Becton, Dickinson and Co. | BDX

Stock Price
192.39
Daily Change
1.13 0.59%
Monthly
11.59%
Yearly
-17.28%
Q3 Forecast
190.79

Peers Price Chg Day Year Date
Terumo 2,657.50 12.00 0.45% -0.95% Sep/08
Agilent 128.75 0.27 0.21% -6.04% Sep/05
Abbott 132.94 0.13 0.10% 16.68% Sep/05
Align Technology 139.12 4.42 3.28% -37.08% Sep/05
Avanos Medical 12.72 0.06 0.47% -46.37% Sep/05
Baxter International 24.42 0.84 3.56% -37.34% Sep/05
Becton, Dickinson and Co. 192.39 1.13 0.59% -17.28% Sep/05
Bio-Rad Laboratories 295.43 6.00 2.07% -10.48% Sep/05
Boston Scientific 107.22 -0.07 -0.07% 31.36% Sep/05
Cooper Companies 68.09 0.09 0.13% -36.13% Sep/05
Danaher 200.21 1.18 0.59% -24.77% Sep/05
Dexcom 80.51 -0.25 -0.31% 17.11% Sep/05
Edwards Lifesciences 80.94 -0.02 -0.02% 21.19% Sep/05
Exact Sciences 53.81 2.40 4.67% -8.97% Sep/05
Globus Medical 60.60 0.31 0.51% -13.42% Sep/05
Hologic 66.76 0.37 0.56% -18.16% Sep/05
Integra LifeSciences 15.99 0.34 2.17% -13.57% Sep/05
Intuitive Surgical 466.86 12.34 2.72% -1.06% Sep/05
J&J 178.43 -0.33 -0.18% 8.51% Sep/05
Masimo 147.19 4.18 2.92% 31.97% Sep/05
Medtronic 92.93 0.13 0.14% 3.32% Sep/05
Insulet 348.43 1.96 0.57% 62.25% Sep/05
Solventum Corp 72.72 0.34 0.47% 9.85% Sep/05
Stryker 392.31 -2.03 -0.51% 9.17% Sep/05
Teleflex 130.70 1.61 1.25% -46.61% Sep/05
Thermo Fisher Scientific 492.60 3.11 0.64% -19.59% Sep/05
Tandem Diabetes Care 12.58 0.19 1.53% -70.33% Sep/05
Dentsply International 14.62 0.29 2.02% -42.75% Sep/05
Zimmer Biomet Holdings 105.73 0.97 0.93% 0.76% Sep/05

Indexes Price Day Year Date
US500 6494 -20.59 -0.32% 18.71% Sep/08

Becton, Dickinson and Co. traded at $192.39 this Friday September 5th, increasing $1.13 or 0.59 percent since the previous trading session. Looking back, over the last four weeks, Becton, Dickinson and Co. gained 11.59 percent. Over the last 12 months, its price fell by 17.28 percent. Looking ahead, we forecast Becton, Dickinson and Co. to be priced at 190.79 by the end of this quarter and at 186.08 in one year, according to Trading Economics global macro models projections and analysts expectations.

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through segments such as BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including medication delivery solutions, medication management solutions, diabetes care and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products.